[go: up one dir, main page]

ES2039313T1 - Nuevos derivados de mediadores endogenos, sus sales, procedimiento de preparacion, aplicaciones, y composiciones que los contienen. - Google Patents

Nuevos derivados de mediadores endogenos, sus sales, procedimiento de preparacion, aplicaciones, y composiciones que los contienen.

Info

Publication number
ES2039313T1
ES2039313T1 ES199191430009T ES91430009T ES2039313T1 ES 2039313 T1 ES2039313 T1 ES 2039313T1 ES 199191430009 T ES199191430009 T ES 199191430009T ES 91430009 T ES91430009 T ES 91430009T ES 2039313 T1 ES2039313 T1 ES 2039313T1
Authority
ES
Spain
Prior art keywords
sub
mineral
carbon atoms
well
applications
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES199191430009T
Other languages
English (en)
Other versions
ES2039313T3 (es
Inventor
Jacques Chauveau
Michel Delaage
Anne Morel
Louis Segu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IMMUNOTECH SA
Original Assignee
IMMUNOTECH SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9006292A external-priority patent/FR2662082B1/fr
Priority claimed from FR9101292A external-priority patent/FR2671971B1/fr
Application filed by IMMUNOTECH SA filed Critical IMMUNOTECH SA
Publication of ES2039313T1 publication Critical patent/ES2039313T1/es
Application granted granted Critical
Publication of ES2039313T3 publication Critical patent/ES2039313T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C229/36—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/78—Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)

Abstract

DERIVADOS DE MOLECULAS BIOLOGICAMENTE ACTIVAS QUE COMPRENDE UNA FUNCION AMINA PRIMARIA Y UN NUCLEO HIDROXILADO ASI COMO SUS SALES DE ADICION CON LOS ACIDOS MINERALES U ORGANICOS, CARACTERIZADOS EN QUE RESPONDEN A LA FORMULA I: [R''R"N-A-B-O-CH SUB 2-CO] SUB NR SUB 1 (1) N REPRESENTA UN NUMERO ENTERO DE 1 A 10; A REPRESENTA UNA CADENA ALQUILENA LINEAL O RAMIFICADA QUE CONTIENE DE 6 A 10 ATOMOS DE CARBONO, PUDIENDO SER SUSTITUIDOS Y EVENTUALMENTE UN HETEROATOMO, O UN GRUPO -B SUB 1-X-B SUB 2-, EN EL QUE B SUB 1 Y B SUB 2 REPRESENTA EL B ANTES CITADO Y X REPRESENTA UN ATOMO DE OXIGENO O UN ATOMO DE OXIGENO O UNA CADENA ALQUILENA QUE CONTIENE DE 1 A 4 ATOMOS DE CARBONO, -R SUB 1 REPRESENTA UN RESTO AMINADO O UN RESTO DE UN ALCOHOL, Y -R'' Y R" REPRESENTAN UN RADICAL ALQUILO QUE CONTIENE DE 1 A 5 ATOMOS DE CARBONO, UN ATOMO DE HIDROGENO O UN RADICAL HIDROFOBO, ASI COMO SUS SALES DE ADICION CON LOS ACIDOS MINERALES U ORGANICOS, ENTENDIENDO QUE R'' Y R" NO PUEDEN REPRESENTAR UN DERIVADO DE 2-HIDROXI-3-FENOXIPROPILO O DE 2-HIDROXI-2-FENILETILO, ASI COMO SUS SALES DE ADICION CON LOS ACIDOS MINERALES U ORGANICOS; PROCESO DE PREPARACION Y APLICACIONES, EN PARTICULAR A LA FORMACION DE IMAGENES, A LA PURIFICACION, A LA PREPARACION DE ANTICUERPOS, A LA DOSIFICACION DE LA HORMONA TOTAL Y COMO MEDICAMENTOS, COMPOSICIONES QUE LOS CONTIENEN Y EQUIPO DE ANALISIS.
ES91430009T 1990-05-15 1991-05-13 Nuevos derivados de mediadores endogenos, sus sales, procedimiento de preparacion, aplicaciones, y composiciones que los contienen. Expired - Lifetime ES2039313T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9006292A FR2662082B1 (fr) 1990-05-15 1990-05-15 Nouveaux derives de mediateurs endogenes, leurs sels, procede de preparation et applications.
FR9101292A FR2671971B1 (fr) 1991-01-30 1991-01-30 Nouveaux derives de la serotonine, application a titre de medicament et compositions les renfermant.

Publications (2)

Publication Number Publication Date
ES2039313T1 true ES2039313T1 (es) 1993-10-01
ES2039313T3 ES2039313T3 (es) 1995-04-16

Family

ID=26228029

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91430009T Expired - Lifetime ES2039313T3 (es) 1990-05-15 1991-05-13 Nuevos derivados de mediadores endogenos, sus sales, procedimiento de preparacion, aplicaciones, y composiciones que los contienen.

Country Status (12)

Country Link
US (1) US5298491A (es)
EP (1) EP0457701B1 (es)
JP (1) JP2968623B2 (es)
KR (1) KR0138750B1 (es)
AT (1) ATE118758T1 (es)
AU (1) AU650265B2 (es)
CA (1) CA2042295A1 (es)
DE (1) DE69107512T2 (es)
DK (1) DK0457701T3 (es)
ES (1) ES2039313T3 (es)
IE (1) IE67888B1 (es)
NO (1) NO308663B1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW288010B (es) * 1992-03-05 1996-10-11 Pfizer
DK0635015T3 (da) * 1992-04-10 1997-03-17 Pfizer Acylaminoindolderivater som 5-Htl agonister
TW251284B (es) * 1992-11-02 1995-07-11 Pfizer
FR2699918B1 (fr) * 1992-12-30 1995-03-17 Pf Medicament Ligands sélectifs des récepteurs 5HY1D-5HT1B dérivés d'indole-pipérazine utiles comme médicaments.
WO1995000541A1 (en) * 1993-06-18 1995-01-05 Hafslund Nycomed A/S Factor vii-derived peptides
WO1998002151A2 (en) 1996-07-12 1998-01-22 Leukosite, Inc. Chemokine receptor antagonists and methods of use therefor
FR2773489B1 (fr) * 1998-01-15 2001-03-23 Immunotech Sa Nouvelle composition destinee a la voie oromuqueuse notamment pernasale
KR100596641B1 (ko) * 1998-12-11 2006-10-04 이승진 진단용 공중합성 미셀 및 그의 제조방법
US7163918B2 (en) * 2000-08-22 2007-01-16 New River Pharmaceuticals Inc. Iodothyronine compositions
US8394813B2 (en) 2000-11-14 2013-03-12 Shire Llc Active agent delivery systems and methods for protecting and administering active agents
US20060014697A1 (en) * 2001-08-22 2006-01-19 Travis Mickle Pharmaceutical compositions for prevention of overdose or abuse
AU2003249582B2 (en) 2002-06-21 2006-08-03 Suven Life Sciences Limited Tetracyclic arylsulfonyl indoles having serotonin receptor affinity
ATE444965T1 (de) 2002-06-21 2009-10-15 Suven Life Sciences Ltd Sich als therapeutische mittel eignende arylalkylindole mit affinität für den serotoninrezeptor, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die diese enthalten
EP1567492B1 (en) 2002-11-28 2013-05-22 Suven Life Sciences Limited N-arylsulfonyl-3-aminoalkoxyindoles
KR100818508B1 (ko) * 2002-11-28 2008-03-31 수벤 라이프 사이언시스 리미티드 세로토닌 수용체 친화력을 가지는 엔-아릴술포닐-3-치환인돌, 그 제조방법 및 그를 포함하는 약제학적 조성물
DE60312226T2 (de) 2002-12-18 2007-11-15 Suven Life Sciences Ltd. Tetrazyklische 3-substituierte indole mit serotoninrezeptoraffinität

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2703325A (en) * 1951-12-06 1955-03-01 Upjohn Co Preparation of 5-benzyloxytryptamines
US3182071A (en) * 1961-06-27 1965-05-04 Warner Lambert Pharmaceutical Acylated indole derivatives
US3686213A (en) * 1970-08-28 1972-08-22 American Cyanamid Co Substituted aminoethyl indoles
US4046636A (en) * 1974-06-20 1977-09-06 Syva Company Diazepam enzyme conjugates
US3878187A (en) * 1972-09-11 1975-04-15 Syva Co Polypeptide derivatives of amphetamine and analogs for immunoassays
US4040907A (en) * 1974-06-20 1977-08-09 Syva Company Iodothyronine enzyme conjugates
DE2737802A1 (de) * 1977-08-22 1979-03-08 Henning Berlin Gmbh Arzneimittel oder diagnostikum zur behandlung oder feststellung von schilddruesenfunktionsstoerungen und verfahren zu dessen herstellung
FR2437398A1 (fr) * 1978-06-20 1980-04-25 Commissariat Energie Atomique Compose iode utilisable comme traceur en radio-immunologie
ZA795239B (en) * 1978-10-12 1980-11-26 Glaxo Group Ltd Heterocyclic compounds
ZW19381A1 (en) * 1980-08-12 1983-03-09 Glaxo Group Ltd Heterocyclic compounds
US4426453A (en) * 1980-09-18 1984-01-17 Amersham International Limited Derivatives of iodothyronine compounds and their use in an assay for the free iodothyronine compounds
EP0099707B1 (en) * 1982-07-16 1986-12-10 Beecham Group Plc 2-aminoethyl ether derivatives, processes for their preparation and pharmaceutical compositions containing them
JPS60132935A (ja) * 1983-12-20 1985-07-16 Sumitomo Chem Co Ltd フエニルセリン誘導体及びその製造方法
FR2562671B1 (fr) * 1984-04-10 1986-07-25 Immunotech Sa Procede pour le dosage immunologique des monoamines
EP0225726B1 (en) * 1985-11-08 1991-04-17 Glaxo Group Limited Indole derivatives
GB8530507D0 (en) * 1985-12-11 1986-01-22 Glaxo Group Plc Chemical compounds
US4910193A (en) * 1985-12-16 1990-03-20 Sandoz Ltd. Treatment of gastrointestinal disorders
DE3628795A1 (de) * 1986-08-25 1988-03-03 Hoechst Ag Neue thyroninderivate
US5019586A (en) * 1987-04-14 1991-05-28 Glaxo Group Limited Ketone derivatives
GB8801306D0 (en) * 1988-01-21 1988-02-17 Ici Plc Chemical compounds
GB8802127D0 (en) * 1988-02-01 1988-03-02 Glaxo Group Ltd Chemical compounds
US4933324A (en) * 1988-02-26 1990-06-12 Shashoua Victor E Fatty acid-neuroactive drug conjugate as a prodrug
FR2662082B1 (fr) * 1990-05-15 1994-12-23 Immunotech Sa Nouveaux derives de mediateurs endogenes, leurs sels, procede de preparation et applications.
FR2671971B1 (fr) * 1991-01-30 1994-01-28 Immunotech Nouveaux derives de la serotonine, application a titre de medicament et compositions les renfermant.

Also Published As

Publication number Publication date
AU650265B2 (en) 1994-06-16
ATE118758T1 (de) 1995-03-15
KR0138750B1 (ko) 1998-05-01
EP0457701A1 (fr) 1991-11-21
AU7704591A (en) 1991-11-21
DE69107512D1 (de) 1995-03-30
ES2039313T3 (es) 1995-04-16
NO911880L (no) 1991-11-18
IE911649A1 (en) 1991-11-20
JP2968623B2 (ja) 1999-10-25
DK0457701T3 (da) 1996-02-05
DE69107512T2 (de) 1995-06-29
KR910020034A (ko) 1991-12-19
NO308663B1 (no) 2000-10-09
IE67888B1 (en) 1996-05-01
JPH04288044A (ja) 1992-10-13
US5298491A (en) 1994-03-29
NO911880D0 (no) 1991-05-14
EP0457701B1 (fr) 1995-02-22
CA2042295A1 (fr) 1991-11-16

Similar Documents

Publication Publication Date Title
ES2039313T3 (es) Nuevos derivados de mediadores endogenos, sus sales, procedimiento de preparacion, aplicaciones, y composiciones que los contienen.
ES539658A0 (es) Procedimiento de preparacion de nuevos derivados de la xan- tina y de sus sales de adicion con acidos apropiados
PT77018B (fr) Procede de preparation de nouveaux derives de la thieno (3,2-c) pyridine et de compositions pharmaceutiques les contenant
CO4790150A1 (es) Inhibidores de metaloproteinasas, composiciones farmaceuti- cas que los contienen y sus farmaceuticos y los metodos e intermedios utiles para su preparacion
ES2142798T3 (es) Derivados de 3-amido pirazol, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
FI810604L (fi) Foerfarande foer framstaellning av indanderivat
ES2117150T3 (es) Derivados tipo 25-acido carboxilico en la serie de la vitamina d, preparados farmaceuticos que contienen dichos derivados y su empleo en la preparacion de medicamentos.
ES2089497T3 (es) Derivados de 23-oxa en la serie de la vitamina d, procedimiento para su preparacion, preparados farmaceuticos que contienen estos derivados asi como su utilizacion como medicamentos.
NO940523D0 (no) Nye pyrazin-derivater
IT1251166B (it) Derivati di geneserina,loro preparazione e composizioni farmaceutiche che li contengono
ES2071666T3 (es) Derivados de pirazoloisoquinolina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ES2102043T3 (es) Derivados de 22-en-25-oxa en la serie de la vitamina d, procedimiento para su preparacion, preparados farmaceuticos que los contienen, asi como su utilizacion en calidad de medicamentos.
EA199800155A1 (ru) Новое соединение
ES2062849T3 (es) Procedimiento para la preparacion de esteres de acido beta-cetocarboxilicos.
IT1190378B (it) Derivati pirrolidonici
FR2660657B1 (fr) Nouveaux derives du 3-aminochromane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
PT84680A (fr) Procede de preparation de derives 1,5-benzothiazepine et de compositions pharmaceutiques les contenant
IT1210926B (it) Derivati della 1-metil-5-nitro-imidazolina e composizioni terapeutiche che li comprendono come principio attivo.
PT78970A (fr) Procede de preparation de derives de triazolo-pyrimidine ayant activite toni-cardiaque et de compositions pharmaceutiques les contenant
DK311585D0 (da) Monobasiske disobutamidderivater og farmaceutisk acceptable syreadditionssalte deraf samt fremgangsmaade til deres fremstilling
ES2085813T3 (es) Mezclas fungicidas.
IT1191109B (it) Derivati di acidi aminopiridincarbossilici,loro metodo di sintesi e composizioni farmaceutiche che li contengono
ES8700653A1 (es) Procedimiento de preparar compuestos amidicos farmacologica-mente activos
DK0865422T3 (da) Anvendelse af aminoalkoholderivater som lægemidler, hidtil ukendte derivater og fremgangsmåde til fremstilling deraf
IT1253007B (it) Derivati dell'eserolina ad attivita' anticolinesterasica,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono

Legal Events

Date Code Title Description
FA2A Application withdrawn

Effective date: 19930312

FG2A Definitive protection

Ref document number: 457701

Country of ref document: ES